| P50 | author | Alison H Harrill | Q62484393 |
| P2093 | author name string | Paul B Watkins | |
| | Rohit Singhal | |
| | Zaid Jayyosi | |
| | Alison H Harrill | |
| | Hadj Benzerdjeb | |
| | Francoise Menguy-Vacheron | |
| P2860 | cites work | Release of chromatin protein HMGB1 by necrotic cells triggers inflammation | Q28131815 |
| | Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity | Q34024427 |
| | Enhanced elimination of warfarin during treatment with cholestyramine | Q34516501 |
| | Review article: pruritus in cholestatic and other liver diseases | Q35091959 |
| | Apoptosis: a mechanism of acute and chronic liver injury | Q36160716 |
| | Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital | Q37346819 |
| | Drug safety sciences and the bottleneck in drug development | Q37877129 |
| | Bile acid sequestrants | Q37906408 |
| | HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease | Q37980335 |
| | Alanine aminotransferase: a clinical and regulatory tool for detecting liver injury-past, present, and future | Q38032729 |
| | Glutamate dehydrogenase: biochemical and clinical aspects of an interesting enzyme | Q39647844 |
| | HMGB1 is an endogenous immune adjuvant released by necrotic cells | Q40104101 |
| | The role of clinical chemistry in chemical and drug safety evaluation by use of laboratory animals | Q40460980 |
| | Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). | Q41875540 |
| | Role of bile acids in liver injury and regeneration following acetaminophen overdose | Q42119327 |
| | The effects of heparins on the liver: application of mechanistic serum biomarkers in a randomized study in healthy volunteers. | Q43137450 |
| | High-mobility group box-1 protein and keratin-18, circulating serum proteins informative of acetaminophen-induced necrosis and apoptosis in vivo | Q43270651 |
| | Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury | Q43278313 |
| | Advantages of glutamate dehydrogenase as a blood biomarker of acute hepatic injury in rats | Q44080665 |
| | Progressive stages of mitochondrial destruction caused by cell toxic bile salts. | Q50983477 |
| | Serum Glutamate Dehydrogenase—Biomarker for Liver Cell Death or Mitochondrial Dysfunction? | Q57724784 |
| | Circulating microRNAs as potential markers of human drug-induced liver injury | Q60609564 |
| | A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. The Lovastatin Study Group III | Q69919273 |
| | Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II | Q70749778 |
| | Regulation of bile acid synthesis in humans: studies on cholesterol 7 alpha-hydroxylation in vivo | Q71450213 |
| | Effect of the interruption of enterohepatic circulation of bile acids by cholestyramine on apolipoprotein gene expression in the rat | Q72184187 |
| | Induction of bile acid synthesis by cholesterol and cholestyramine feeding is unimpaired in mice deficient in apolipoprotein AI | Q73229704 |
| | Effect of cholesterol, cholic acid and cholestyramine administration on the intestinal mRNA expressions related to cholesterol and bile acid metabolism in the rat | Q80323234 |
| P921 | main subject | biomarker | Q864574 |
| | hepatotoxicity | Q1349821 |
| P304 | page(s) | 42 | |
| P577 | publication date | 2014-08-03 | |
| P1433 | published in | BMC pharmacology & toxicology | Q27724429 |
| P1476 | title | Benign elevations in serum aminotransferases and biomarkers of hepatotoxicity in healthy volunteers treated with cholestyramine | |
| P478 | volume | 15 | |